Показано 0 из 0
Дата |
---|
16:29 |
02.07.2024 |
01.07.2024 |
28.06.2024 |
27.06.2024 |
26.06.2024 |
25.06.2024 |
24.06.2024 |
21.06.2024 |
20.06.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.476
|
0.526
|
0.424
|
0.424
|
0.476
|
0.476
|
|
|
|
|
0.424
|
0.518
|
0.442
|
0.442
|
0.475
|
0.466
|
|
|
|
|
0.442
|
0.54
|
0.44
|
0.44
|
0.516
|
0.516
|
|
|
258.00
|
5.00
|
0.44
|
0.538
|
0.451
|
0.451
|
0.474
|
0.474
|
|
|
|
|
0.48
|
0.56
|
0.56
|
0.504
|
0.56
|
0.504
|
|
|
2 602.90
|
6.00
|
0.50
|
0.562
|
0.50
|
0.50
|
0.55
|
0.526
|
|
|
2 622.90
|
3.00
|
0.453
|
0.554
|
0.468
|
0.468
|
0.504
|
0.495
|
|
|
|
|
0.468
|
0.572
|
0.469
|
0.468
|
0.487
|
0.487
|
|
|
|
|
0.469
|
0.574
|
0.478
|
0.478
|
0.504
|
0.504
|
|
|
|
|
0.478
|
0.584
|
0.469
|
0.469
|
0.506
|
0.504
|
|
|
|
|
BenevolentAI is a leading, clinical-stage AI drug discovery company. Through the combined capabilities of its AI platform, scientific expertise and wet-lab facilities, BenevolentAI is well-positioned to deliver novel drug candidates with a higher probability of clinical success than those developed using traditional methods.